| ¿µ¹® | methotrexate | ÇÑ±Û | ¸ÞÅ䯮·º¼¼ÀÌÆ® |
|---|---|---|---|
| ¼³¸í | µî°¥»öÀÇ °áÁ¤¼º ºÐ¸». ¿±»ê´ëÇ×Á¦À̸ç Ç×Á¾¾çÁ¦·Î¼ ±Þ¼º ¹× ¾Æ±Þ¼º ¹éÇ÷º´, ¼ö¸·¹éÇ÷º´, Àӽżº À¶¸ð¾Ï, À¶¸ð¸·»ùÁ¾, Æ÷µµ¸ð¾ç±âÅÂ, °¢¼º¸²ÇÁÁ¾ÁøÇà±âÀÇ Ä¡·á¿¡ »ç¿ëµÇ¸ç ¶ÇÇÑ ÇװǼ±Á¦·Î »ç¿ëµÈ´Ù. °æ±¸Åõ¿© ¶Ç´Â ±ÙÀ°ÁÖ»çÇÑ´Ù. ¸é¿ª¾ïÁ¦Á¦·Î¼ ¸é¿ª¸Å°³ º´¿¡µµ »ç¿ëµÈ´Ù. |
||
| CAMP | Cyclophosphamide, Adriamycin(Doxorubicin), Methotrexate, Procarbazine |
|---|---|
| MTX | MethoTreXate |
| MVAC | Methotrexate, Vinblastin, Adriamycin(= Doxorubicin), Cisplatin |
| ACM | acetaminophen; acute cerebrospinal meningitis; Adriamycin, cyclophosphamide, methotrexate; albumin- ... |
| CAMF | cyclophosphamide, Adriamycin, methotrexate, fluorouracil |
| 7-OH-MTX | 7-Hydroxy-methotrexate |
|---|---|
| M | C)/methotrexate |
| CMF | Cyclophosphamide, Methotrexate and 5-Fluorouracil |
| CMF | Cyclophosphamide, Methotrexate, Fluorouracil |
| HDMtx | High dose Methotrexate |
| methotrexate | <drug> Analogue of dihydrofolate. Inhibits dihydrofolate reductase and kills rapidly growing cells. Therapeutic agent for leukaemias, but has a low therapeutic ratio. (18 Nov 1997) |
|---|
Synonyms : Methotrexate Hydrate, Methotrexate, (D)-Isomer, Methotrexate, (DL)-Isomer, Methotrexate, Dicesium Salt, Methotrexate, Disodium Salt, Methotrexate, Sodium Salt, Mexate, Dicesium Salt Methotrexate, Disodium Salt Methotrexate, Hydrate, Methotrexate
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
¿¥Åؼ¼ÀÌÆ®ÇÇ¿¡ÇÁÁÖ»ç10ml - »õâ
|
Pharmachemie |
W01510131 | Methotrexate | Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ |
|
¿¥Æ¼¿¢½ºÁ¤ - »õâ
|
Áᨚ |
A02103491 | Methotrexate | Àü¹®ÀǾàǰ | ±Þ¿© |
|
Çѱ¹À¯³ªÀÌÆ¼µå¸ÞÅ䯮·º¼¼ÀÌÆ®Á¤ - »õâ
|
Çѱ¹À¯³ªÀÌÆ¼µåÁ¦¾à |
A12902461 | Methotrexate | Àü¹®ÀǾàǰ | ±Þ¿© |
|
À¯ÇѸÞÅ䯮·º¼¼ÀÌÆ®Á¤ - »õâ
|
À¯ÇѾçÇà |
A04503121 | Methotrexate | Àü¹®ÀǾàǰ | ±Þ¿© |
|
À¯´ÏÆ®·º¼¼ÀÌÆ®ÁÖ500mg - »õâ
|
Çѱ¹À¯³ªÀÌÆ¼µåÁ¦¾à |
A12900041 | Methotrexate | Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ |
|
À¯ÇѸÞÅ䯮·º¼¼ÀÌÆ®ÁÖ»ç¾×500mg/20ml - »õâ
|
À¯ÇѾçÇà |
A04504551 | Methotrexate | Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ |
|
¿¥Æ¼¿¢½ºÁÖ500mg - »õâ
|
Áᨚ |
A02104641 | Methotrexate | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¿¥Åؼ¼ÀÌÆ®ÇÇ¿¡ÇÁÁÖ»ç2.5%2ml - »õâ
|
Pharmachemie |
W01510121 | Methotrexate | Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ |
|
³ì½ÊÀÚ¸ÞÅ䯮·º¼¼ÀÌÆ®ÁÖ - »õâ
|
³ì½ÊÀÚ |
A10201481 | Methotrexate | Àü¹®ÀǾàǰ | »èÁ¦ |
|
³×¿À¸ÞÅäÁÖ50mg - »õâ
|
º¸·ÉÁ¦¾à |
A09303091 | Methotrexate | Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ |
| methotrexate sodium |
methotrexate: toxic antimetabolite that limits cellular reproduction by acting as an antagonist to folic acid; used to treat certain cancers and psoriasis and rheumatoid arthritis
Ãâó: wordnet.princeton.edu/perl/webwn
|
|---|---|
| methotrexate |
[USP] a folic acid antagonist that acts by inhibiting synthesis of DNA, RNA, thymidylate, and protein; used as an antineoplastic in treatment of a wide variety of malignancies, including acute lymphocytic, meningeal, and acute myelocytic leukemia; gestational choriocarcinoma; chorioadenoma destruens; hydatidiform mole; carcinoma of the breast, lung, and head and neck; non-Hodgkin's lymphomas; mycosis fungoides; and osteosarcoma; administered orally. It is also used as an antipsoriatic and antiarthritic in the treatment of severe, recalcitrant, disabling psoriasis and severe rheumatoid and psoriatic arthritis.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| Methotrexate | toxic antimetabolite that limits cellular reproduction by acting as an antagonist to folic acid |
|---|---|
| Methotrexate | toxic antimetabolite that limits cellular reproduction by acting as an antagonist to folic acid |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|